Periodic Reporting for period 1 - platinDx (A test for predicting the efficacy of common platinum drugs enabling personalized chemotherapy for bladder cancer patients.)

AMD undertook the feasibility study from May 1 to October 31 2015 with the objective to assess the commercial potential of their PlatinDx test and to outline a strategy for commercialisation in the EU.